Best supportive care and symptom palliation are mainstays of treatment for patients with interstitial pulmonary fibrosis (IPF). As the disease advances, breathlessness becomes a major determinant of quality of life,  yet anecdotal evidence suggests some patients are reluctant to instigate oxygen therapy . This rapid review was conducted to understand key facilitators and barriers to the use of oxygen therapy from the perspective of patients with IPF and their carers.